Ingevity Quarterly Balance Sheet
NYSE: NGVTIndustrialsMajor ChemicalsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ingevity financial position
As of Jun 30, 2026, Ingevity reported total assets of $1.54 billion, down 18.1% from a year earlier against total liabilities of $1.49 billion. Shareholders' equity stood at $46.9 million, or 3.1% of assets. The company held $97.4 million in cash and equivalents against $1.20 billion of debt, a net debt position of $1.10 billion.
The current ratio (current assets divided by current liabilities) was 1.61, meaning short-term assets cover obligations due within a year. Debt-to-equity was 25.59.
Summary generated from market data by MetaCap's automated system. Methodology
Ingevity balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 97.40M | 95.40M | 78.10M | 83.40M | 76.90M | 71.50M | 68.00M | 135.50M | 107.40M | 88.50M | 95.90M | 84.50M |
| Inventory | 154.00M | 203.60M | 186.00M | 193.70M | 220.30M | 245.40M | 195.90M | 261.00M | 302.00M | 325.50M | 308.80M | 386.70M |
| Total Current Assets | 543.80M | 581.80M | 454.20M | 522.20M | 536.00M | 530.00M | 493.20M | 636.80M | 685.80M | 669.20M | 658.60M | 734.50M |
| Property, Plant & Equipment | 575.00M | 599.80M | 608.10M | 629.70M | 654.60M | 655.80M | 642.90M | 671.30M | 722.20M | 726.50M | 762.20M | 800.00M |
| Goodwill | 4.30M | 4.30M | 4.30M | 4.30M | 4.30M | 180.70M | 175.20M | 186.90M | 177.00M | 525.90M | 527.50M | 520.10M |
| Intangible Assets | 137.30M | 168.00M | 176.10M | 267.60M | 279.10M | 276.80M | 278.80M | 298.60M | 295.70M | 302.80M | 336.10M | 375.60M |
| Total Assets | 1.54B | 1.65B | 1.65B | 1.83B | 1.88B | 2.06B | 2.02B | 2.21B | 2.28B | 2.57B | 2.62B | 2.77B |
| Accounts Payable | 88.00M | 85.00M | 92.00M | 100.90M | 101.50M | 108.30M | 94.50M | 96.50M | 142.40M | 153.10M | 158.40M | 197.30M |
| Short-Term Debt | 144.00M | 121.90M | 47.10M | 102.00M | 94.70M | 60.40M | 61.30M | 100.70M | 103.00M | 84.70M | 84.40M | 3.00M |
| Total Current Liabilities | 337.60M | 409.40M | 341.30M | 411.60M | 393.10M | 264.60M | 264.10M | 360.80M | 357.80M | 351.70M | 362.90M | 305.10M |
| Long-Term Debt | 1.06B | 1.08B | 1.16B | 1.16B | 1.24B | 1.33B | 1.34B | 1.40B | 1.40B | 1.41B | 1.38B | 1.47B |
| Total Liabilities | 1.49B | 1.61B | 1.62B | 1.70B | 1.76B | 1.82B | 1.83B | 2.00B | 1.99B | 2.00B | 1.99B | 2.05B |
| Shareholders' Equity | 46.90M | 38.90M | 29.70M | 138.10M | 120.70M | 234.60M | 195.20M | 214.50M | 284.80M | 568.20M | 631.40M | 718.70M |
| Retained Earnings | 500.00M | 464.70M | 404.90M | 489.50M | 446.00M | 592.50M | 572.00M | 555.40M | 662.60M | 946.30M | 1.00B | 1.12B |
| Total Debt | 1.20B | 1.20B | 1.21B | 1.26B | 1.33B | 1.39B | 1.40B | 1.50B | 1.50B | 1.49B | 1.47B | 1.47B |
| Net Cash (Debt) | -1.10B | -1.11B | -1.13B | -1.18B | -1.25B | -1.32B | -1.33B | -1.36B | -1.40B | -1.40B | -1.37B | -1.39B |
| Shares Outstanding | 34.48M | 34.89M | 35.49M | 36.05M | 36.47M | 36.45M | 36.35M | 36.35M | 36.34M | 36.32M | 36.23M | 36.23M |
This table shows 12 quarterly periods of Ingevity's balance sheet, from Q2 2026 back to Q3 2023, across 19 line items including cash & equivalents, receivables, inventory. Values in USD; B = billions, M = millions. Fiscal periods follow NGVT's reporting calendar. What is a balance sheet?